Scholar Rock Holding (SRRK) Current Assets (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Current Assets came in at $515.3 million in Q1 2026, up 33.75% year-on-year from $385.2 million in Q1 2025, and up 33.79% quarter-over-quarter from $385.1 million in Q4 2025.
Scholar Rock Holding (SRRK) Current Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Current Assets history runs 10 years deep, the most recent figure standing at $515.3 million for Q1 2026.
- On a quarterly basis, Current Assets rose 33.75% year-over-year to $515.3 million in Q1 2026; TTM through Mar 2026 was $515.3 million, a 33.75% increase from a year earlier, with the FY2025 full-year figure at $385.1 million, down 14.63% from the prior year.
- Current Assets improved to $515.3 million in Q1 2026 per SRRK's latest filing, from $385.1 million in the prior quarter.
- Across five years, Current Assets topped out at $515.3 million in Q1 2026 and bottomed at $152.9 million in Q3 2024.
- The 5-year median for Current Assets is $319.1 million (2025), against an average of $318.4 million.
- Across the five-year window, Current Assets sank 36.11% in 2023 and jumped 155.49% in 2025, its largest moves.
- Year by year, Current Assets stood at $328.0 million in 2022, then dropped by 12.14% to $288.2 million in 2023, then jumped by 56.55% to $451.2 million in 2024, then dropped by 14.63% to $385.1 million in 2025, then jumped by 33.79% to $515.3 million in 2026.
- Per Business Quant, the three latest SRRK Current Assets figures stand at $515.3 million (Q1 2026), $385.1 million (Q4 2025), and $390.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | 515.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 515.28 Mn |
| Dec 31, 2025 | 385.15 Mn |
| Sep 30, 2025 | 390.71 Mn |
| Jun 30, 2025 | 319.13 Mn |
| Mar 31, 2025 | 385.25 Mn |
| Dec 31, 2024 | 451.17 Mn |
| Sep 30, 2024 | 152.93 Mn |
| Jun 30, 2024 | 199.14 Mn |
| Mar 31, 2024 | 246.93 Mn |
| Dec 31, 2023 | 288.19 Mn |
| Sep 30, 2023 | 228.47 Mn |
| Jun 30, 2023 | 259.81 Mn |
| Mar 31, 2023 | 287.16 Mn |
| Dec 31, 2022 | 328.02 Mn |
| Sep 30, 2022 | 357.61 Mn |
| Jun 30, 2022 | 389.14 Mn |
| Mar 31, 2022 | 228.59 Mn |
| Dec 31, 2021 | 265.32 Mn |
| Sep 30, 2021 | 258.16 Mn |
| Jun 30, 2021 | 290.37 Mn |